What is the main business of Mmoncovacs?

The main business activity of Mmoncovacs focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 8, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Bolesława Prusa 22, 62-002 Złotniki.

Who is on the management board?

The management board consists of: Andrzej Adam Mackiewicz (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

Mmoncovacssp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-06-08

Share capital

5,000.00 PLN

Registered address

ul. Bolesława Prusa 22, 62-002 Złotniki, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 586 days for 2020).

2023not filed
202224/05/2023
202124/05/2023
202024/05/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Authorized Representatives

Andrzej Adam Mackiewicz – President of the Management Board

Manner of representation

In the case of a multi-member management board, each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Andrzej Adam Mackiewiczage 73	80	$1,080.50	80%
Jacek Mackiewiczage 47	20	$270.12	20%

Andrzej Adam Mackiewicz and Jacek Mackiewicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-08-25 to 2025-01-16.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
GenxoneS.A.	$665,361.35	genxone.eu
Polbiotech Laboratoriumsp. z o.o.	$645,943.81	polbiotech.pl
Explorna Therapeuticssp. z o.o.	$304,662.00	explorna.com
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
Xenstatssp. z o.o.	$66,774.27	xenstats.com
Fungotechsp. z o.o.	$187.68	fungo.tech
Ncage TherapeuticsS.A.	$29.14	ncage.org
Dystrogen TherapeuticsS.A.	–	dystrogen.com
MIMO BiotechP.S.A.	–	mimobiotech.com

Change history

Date	Event
2022-12-09	Name change (Covidvax → Mmoncovacs)
2020-06-08	Entered in the register

FAQ

Last updated: 2026-04-19